Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Array Bio ends late-stage study of ovarian cancer drug
Array Bio ends late-stage study of ovarian cancer drug
Array Bio ends late-stage study of ovarian cancer drug
Submitted by
admin
on April 1, 2016 - 10:16am
Source:
Yahoo/Reuters
News Tags:
Array Biopharma
clinical trials
ovarian cancer
binimetinib
Headline:
Array Bio ends late-stage study of ovarian cancer drug
Do Not Allow Advertisers to Use My Personal information
